HUMAN GENOME SCIENCES INC Sales Revenue, Services, Net (Deprecated 2018-01-31)
HUMAN GENOME SCIENCES INC reported Sales Revenue, Services, Net (Deprecated 2018-01-31) of $15.49 million for the 3-month period ending 2012-06-30, per its 10-Q filed 2012-07-26.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SalesRevenueServicesNet · last filed 2012-07-26
- HUMAN GENOME SCIENCES INC sales revenue, services, net (deprecated 2018-01-31) for the quarter ending 2012-06-30 was $15.49M, a 287.23% increase year-over-year.
- HUMAN GENOME SCIENCES INC sales revenue, services, net (deprecated 2018-01-31) for the quarter ending 2012-03-31 was $9.51M, a 22.48% decline year-over-year.
- HUMAN GENOME SCIENCES INC sales revenue, services, net (deprecated 2018-01-31) for the quarter ending 2011-12-31 was $5.83M, a 22.47% decline year-over-year.
- HUMAN GENOME SCIENCES INC sales revenue, services, net (deprecated 2018-01-31) for the quarter ending 2011-09-30 was $2.75M, a 51.61% decline year-over-year.
- HUMAN GENOME SCIENCES INC sales revenue, services, net (deprecated 2018-01-31) for fiscal 2011 was $24.84M, a 9.45% increase from fiscal 2010.
- HUMAN GENOME SCIENCES INC sales revenue, services, net (deprecated 2018-01-31) for fiscal 2010 was $22.70M, a 55.20% decline from fiscal 2009.
- HUMAN GENOME SCIENCES INC sales revenue, services, net (deprecated 2018-01-31) for fiscal 2009 was $50.65M.
| Period end | Sales Revenue, Services, Net (Deprecated 2018-01-31) 3 month | Sales Revenue, Services, Net (Deprecated 2018-01-31) 6 month | Sales Revenue, Services, Net (Deprecated 2018-01-31) 9 month | Sales Revenue, Services, Net (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2012-06-30 | $15.49M 10-Q · filed 2012-07-26 | $25.00M 10-Q · filed 2012-07-26 | $30.82M derived: sum of 3 quarters · filed 2012-07-26 | $33.57M derived: sum of 4 quarters · filed 2012-07-26 |
| 2012-03-31 | $9.51M 10-Q · filed 2012-04-26 | $15.34M derived: sum of 2 quarters · filed 2012-04-26 | $18.08M derived: sum of 3 quarters · filed 2012-04-26 | $22.08M derived: sum of 4 quarters · filed 2012-07-26 |
| 2011-12-31 | $5.83M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $8.58M derived: sum of 2 quarters · filed 2012-02-28 | $12.58M derived: sum of 3 quarters · filed 2012-07-26 | $24.84M 10-K · filed 2012-02-28 |
| 2011-09-30 | $2.75M 10-Q · filed 2011-10-28 | $6.75M derived: sum of 2 quarters · filed 2012-07-26 | $19.01M 10-Q · filed 2011-10-28 | $26.53M derived: sum of 4 quarters · filed 2012-07-26 |
| 2011-06-30 | $4.00M 10-Q · filed 2012-07-26 | $16.26M 10-Q · filed 2012-07-26 | $23.78M derived: sum of 3 quarters · filed 2012-07-26 | $29.46M derived: sum of 4 quarters · filed 2012-07-26 |
| 2011-03-31 | $12.26M 10-Q · filed 2012-04-26 | $19.78M derived: sum of 2 quarters · filed 2012-04-26 | $25.46M derived: sum of 3 quarters · filed 2012-04-26 | $30.84M derived: sum of 4 quarters · filed 2012-04-26 |
| 2010-12-31 | $7.52M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $13.20M derived: sum of 2 quarters · filed 2012-02-28 | $18.57M derived: sum of 3 quarters · filed 2012-02-28 | $22.70M 10-K · filed 2012-02-28 |
| 2010-09-30 | $5.68M 10-Q · filed 2011-10-28 | $11.06M derived: sum of 2 quarters · filed 2011-10-28 | $15.18M 10-Q · filed 2011-10-28 | |
| 2010-06-30 | $5.38M 10-Q · filed 2011-07-28 | $9.50M 10-Q · filed 2011-07-28 | ||
| 2010-03-31 | $4.12M 10-Q · filed 2011-04-29 | |||
| 2009-12-31 | $50.65M 10-K · filed 2012-02-28 |